The history of injectable facial fillers.
Kontis TC, Rivkin A.
Facial Plast Surg. 2009 May;25(2):67-72. doi: 10.1055/s-0029-1220645. Epub 2009 May 4.
Lip Implants.
Brody-Camp S, Raggio BS.
2023 May 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
N,N´-Bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl-3-methoxypropyl)-acetamidol]-2,4,6-triiodoisophthalamide.
Cheng KT.
2006 Mar 6 [updated 2008 Mar 4]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.
N,N´-Bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)-glycolamidol]-2,4,6-triiodoisophthalamide.
Cheng KT.
2006 Feb 7 [updated 2008 Feb 7]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.
Radiance.
Flaharty P.
Facial Plast Surg. 2004 May;20(2):165-9. doi: 10.1055/s-2004-861759.
Introduction to Fillers.
Carruthers J, Carruthers A, Humphrey S.
Plast Reconstr Surg. 2015 Nov;136(5 Suppl):120S-131S. doi: 10.1097/PRS.0000000000001770.
Capronor.
Research Triangle Institute.
Hypotenuse. 1985 May-Jun:2-5.
Filling the void: a case of sepsis following the injection of a penile bulking agent.
Redmond E, Forde JC, Flood HD.
BMJ Case Rep. 2014 Mar 26;2014:bcr2013203054. doi: 10.1136/bcr-2013-203054.
5-[3-Hydroxy-2-hydroxymethyl-propionamido)-N,N´-dimethyl-N,N´-bis-(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide.
Cheng KT.
2006 May 16 [updated 2008 Apr 21]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.
N-(2,3-Dihydroxypropyl)-N´-(2-hydroxyethyl)-5-[N-(2,3-dihydroxypropyl)acetamido]-2,4,6-triiodoisophthalamide.
The MICAD Research Team.
2006 Jul 12 [updated 2006 Aug 9]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.
